English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Dec 12, 2025

FDA may add black box warning to some COVID-19 vaccines following internal review
+ Pharmaceuticals
Patient Daily | Dec 12, 2025

Instability at FDA raises concerns over lack of process in regulatory decisions
+ Pharmaceuticals
Patient Daily | Dec 11, 2025

FDA faces instability amid leadership turnover and concerns over new policies
+ Pharmaceuticals
Patient Daily | Dec 11, 2025

FDA halts Denali's Pompe therapy over preclinical safety signals
+ Pharmaceuticals
Patient Daily | Dec 11, 2025

Praxis halts epilepsy trial early after positive results; prepares for FDA discussions
+ Pharmaceuticals
Patient Daily | Dec 11, 2025

CDC advisory panel recommends delaying hepatitis B vaccine dose for some newborns
+ Pharmaceuticals
Patient Daily | Dec 11, 2025

FDA plans to lower clinical trial requirements for new drug approvals
+ Pharmaceuticals
Patient Daily | Dec 11, 2025

Crescent Biopharma and Kelun-Biotech sign cancer therapy deal worth up to $1.25 billion

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation